Artelo Biosciences Stock Today
| ARTL Stock | USD 0.95 0.03 3.26% |
PerformanceWeak
| Odds Of DistressHigh
|
Artelo Biosciences is selling for 0.95 as of the 20th of March 2025. This is a 3.26 percent increase since the beginning of the trading day. The stock's lowest day price was 0.91. Artelo Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. The company has 3.28 M outstanding shares of which 13.42 K shares are presently shorted by private and institutional investors with about 0.04 trading days to cover. More on Artelo Biosciences
Moving together with Artelo Stock
Moving against Artelo Stock
Artelo Stock Highlights
| Old Name | Alpha Real Trust Ltd |
| Business Concentration | Business Services, Biotechnology, Healthcare, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Artelo Biosciences (ARTL) is traded on NASDAQ Exchange in USA. It is located in 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075 and employs 6 people. Artelo Biosciences is listed under Business Services category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.02 M. Artelo Biosciences conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 3.28 M outstanding shares of which 13.42 K shares are presently shorted by private and institutional investors with about 0.04 trading days to cover.
Artelo Biosciences currently holds about 21.32 M in cash with (8.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Artelo Biosciences Probability Of Bankruptcy
Ownership AllocationAlmost 98.14 percent of Artelo Biosciences outstanding shares are held by general public with 0.81 (percent) owned by insiders and only 1.05 % by other corporate entities.
Check Artelo Ownership Details
Artelo Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Artelo Biosciences market risk premium is the additional return an investor will receive from holding Artelo Biosciences long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0245 | |||
| Jensen Alpha | 0.0417 | |||
| Total Risk Alpha | 0.3969 | |||
| Sortino Ratio | 0.0383 |
Artelo Stock Against Markets
Artelo Biosciences Corporate Management
| Jason Baybutt | Senior Finance | Profile | |
| Andrew Yates | Senior Officer | Profile | |
| Steven Reich | Chief Officer | Profile | |
| Steven MD | Chief Officer | Profile | |
| Gregory MBA | CEO and President | Profile |
Already Invested in Artelo Biosciences?
The danger of trading Artelo Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Artelo Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Artelo Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Artelo Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Artelo Biosciences is a strong investment it is important to analyze Artelo Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Artelo Biosciences' future performance. For an informed investment choice regarding Artelo Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Artelo Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.